M&A Deal Summary |
|
---|---|
Date | 2020-06-02 |
Target | Soluble Therapeutics |
Sector | Life Science |
Buyer(s) | Predictive Oncology |
Sellers(s) | CytoBioscience |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2002 |
Sector | Life Science |
Employees | 22 |
Revenue | 1M USD (2020) |
Predictive Oncology operates through three segments (Domestic, International, and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical, and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. Predictive Oncology was founded in 2002 and is based in Eagan, Minnesota.
DEAL STATS | # |
---|---|
Overall | 2 of 3 |
Sector (Life Science) | 2 of 3 |
Type (Divestiture) | 2 of 2 |
State (Alabama) | 2 of 2 |
Country (United States) | 2 of 3 |
Year (2020) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-06-02 |
BioDtech
Birmingham, Alabama, United States BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-01 |
zPREDICTA
San Jose, California, United States zPREDICTA develops tumor-specific in vitro models for oncology drug discovery and research. Its mission is to accelerate the drug development process for pharmaceutical clients and partners. Based on their proprietary models, zPREDICTA offers preclinical testing services to clients in the biopharmaceutical industry and through its partnership with a large pharma company. zPREDICTA was founded in 2014 and is based in San Jose, California. |
Buy | - |
CytoBioscience, Inc. is a manufacturer of devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Life Science) | 2 of 2 |
Type (Divestiture) | 2 of 2 |
State (Alabama) | 2 of 2 |
Country (United States) | 2 of 2 |
Year (2020) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-06-02 |
BioDtech
Birmingham, Alabama, United States BioDtech, Inc. develops and markets products for the detection, neutralization, and removal of biological toxins for pharmaceutical manufacturing and clinical applications. BioDtech was founded in 2003 and is based in Birmingham, Alabama. |
Sell | - |